Prognostic value of MRI-derived features for biochemical recurrence after curative radiotherapy in prostate cancer
Authors:
- Alexander HeroldAHAlexander Herold
- Maximilian PohlMPMaximilian Pohl
- Stephan M. KornSKStephan M. Korn
- Michael WeberMWMichael Weber
- Jason A. EfstathiouJEJason A. Efstathiou
- Philip J. SaylorPSPhilip J. Saylor
- Susie Y. HuangSHSusie Y. Huang
- Mukesh G. HarisinghaniMHMukesh G. Harisinghani
- Onofrio A. CatalanoOCOnofrio A. Catalano
- 20 September 2025
- journal article
- research article
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (4) , 2125-2136
Abstract
Background To evaluate whether pretreatment multiparametric MRI features can predict biochemical recurrence in patients with localized prostate cancer treated with radiation therapy of curative intent. Methods This retrospective single-institution study analyzed patients with prostate cancer who underwent primary radiotherapy between January 2015 and December 2019. All patients underwent pretreatment multiparametric MRI, with or without endorectal coil. Clinical, pathological and MRI features were assessed, with emphasis on qualitative and quantitative imaging characteristics. Univariate binary logistic regression identified significant predictors of recurrence. Variables showing significance (p < 0.05) were included in forward stepwise logistic regression analysis. The primary endpoint was biochemical recurrence, defined by Phoenix criteria. Results The study included 54 patients (mean age 76.57 ± 7.77 years), with 10 patients (18.5%) experiencing biochemical recurrence at a median follow-up of 74.4 months. In univariate analysis, clinical T-stage (OR: 2.24, 95% CI: 1.11–4.56), ISUP grade (OR: 1.86, 95% CI: 1.03–3.37) and NCCN risk groups (OR: 2.55, 95% CI: 1.16–5.62) were significant predictors. Among MRI parameters, total tumor volume (OR: 4.28, 95% CI: 1.59–11.57), extraprostatic extension (OR: 8.57, 95% CI: 1.61–45.73), neurovascular bundle invasion (NBI) (OR: 14.78, 95% CI: 2.97–73.44), and seminal vesicle invasion (OR: 15.00, 95% CI: 2.94–76.56) showed strong associations with recurrence. In stepwise multivariate analysis, NBI emerged as the sole independent predictor (OR: 3.16, 95% CI: 1.59–6.28, p = 0.001), with 86.4% specificity and 92.7% negative predictive value. Conclusion NBI on pretreatment MRI independently predicts biochemical recurrence in patients with localized prostate cancer treated with radiation therapy, highlighting the need to refine risk stratification by incorporating imaging criteria.Keywords
This publication has 29 references indexed in Scilit:
- EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative IntentEuropean Urology, 2024
- Radiation Therapy Summary of the AUA/ASTRO Guideline on Clinically Localized Prostate CancerPractical Radiation Oncology, 2024
- Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical ProstatectomyJAMA Network Open, 2023
- Outcomes after definitive radiation therapy for localized prostate cancer in a national health care delivery systemCancer, 2023
- Can Pre-treatment Quantitative Multi-parametric MRI Predict the Outcome of Radiotherapy in Patients with Prostate Cancer?Academic Radiology, 2022
- Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2European Urology, 2019
- Pretreatment Multiparametric Magnetic Resonance Imaging Findings Are More Accurate Independent Predictors of Outcome Than Clinical Variables in Localized Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2018
- Does Local Recurrence of Prostate Cancer After Radiation Therapy Occur at the Site of Primary Tumor? Results of a Longitudinal MRI and MRSI StudyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Predicting Post–External Beam Radiation Therapy PSA Relapse of Prostate Cancer Using Pretreatment MRIInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysisClinical Radiology, 2008